BMPR1B

Bone morphogenetic protein receptor type-1B · O00238 · BMPR1B on Sugi Atlas →

43,355 patent compounds predicted against BMPR1B, 32,571 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Vandetanib Vandetanib (SCHEMBL9044) 1.00 1/20
Saracatinib Saracatinib (SCHEMBL41547) 1.00 1/20
Canertinib Canertinib (SCHEMBL54837) 1.00 1/20
Quizartinib Quizartinib (SCHEMBL72923) 1.00 1/20
Ruxolitinib Ruxolitinib (SCHEMBL99225) 1.00 1/20
Ruxolitinib Ruxolitinib (SCHEMBL101279) 1.00 1/20
Plx-4720 Plx-4720 (SCHEMBL133733) 1.00 1/20
Quizartinib Quizartinib (SCHEMBL74121) 0.99 1/20
Dasatinib Anhydrous Dasatinib Anhydrous (SCHEMBL8226) 0.98 1/20
SCHEMBL99245 SCHEMBL99245 0.98 1/20
SCHEMBL99371 SCHEMBL99371 0.98 1/20
SCHEMBL103135 SCHEMBL103135 0.98 1/20
SCHEMBL73633 SCHEMBL73633 0.93 1/20
SCHEMBL98692 SCHEMBL98692 0.92 1/20
SCHEMBL72924 SCHEMBL72924 0.91 1/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL74122) 0.90 1/20
SCHEMBL73035 SCHEMBL73035 0.88 1/20
SCHEMBL73476 SCHEMBL73476 0.88 1/20
SCHEMBL74273 SCHEMBL74273 0.87 1/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL73806) 0.87 1/20

Clinical trials — most relevant to BMPR1B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Vitamin D and Carboxy PTH Fragments in Coronary Calcification PHASE4WITHDRAWN
Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study) PHASE4COMPLETED
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor PHASE1/PHASE2COMPLETED
The Use of Adhesion Molecule Loaded Hydrogel With Minimally Invasive Surgical Technique in Treatment of Periodontal Intrabony Defect PHASE1/PHASE2COMPLETED
Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat) PHASE2COMPLETED
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer PHASE2COMPLETED
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy PHASE1COMPLETED
Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies nanUNKNOWN
Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension nanCOMPLETED
Genetic and Environmental Characteristics of Primary Pulmonary Hypertension nanCOMPLETED
StratosPHere (Non-interventional Study) nanCOMPLETED
Short-term Impact of Cyplexinol® on Self-reported Joint Pain nanCOMPLETED
Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention nanUNKNOWN
Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers nanCOMPLETED
Genes-in-Action - Hepcidin Regulation of Iron Supplementation nanCOMPLETED
Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension nanUNKNOWN
BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension nanCOMPLETED
Early Regenerative Intervention for Post-Traumatic Osteoarthritis nanUNKNOWN
Gremlin-1 and Wagner Classification: Potential Biomarker for Amputation in Diabetic Foot Patients nanCOMPLETED
National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension nanUNKNOWN
Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension nanCOMPLETED
AO CSH Mainstream Study on Cervical Spine Degeneration nanNOT_YET_RECRUITING
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals nanRECRUITING
Therapeutic Irrigation Procedures to Treat Apical Periodontitis nanCOMPLETED
Induce XT™ Bone Graft in Foot and Ankle Fusion nanENROLLING_BY_INVITATION
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH nanWITHDRAWN
Transcription Factor Runx2 in Necrotic Femoral Head Tissue nanCOMPLETED
Osteoprosis in Type 2 Diabetic Patients- a Cohort Study nanUNKNOWN
Immediate Implants in Maxillary Premolar Region Using Xenograft vs Allograft nanUNKNOWN
Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a BMPR1B binder may also engage these)

ProteinNameSimilarity
Q05438 1.000 Q05438 →
Q78EA7 1.000 Q78EA7 →
P80202 1.000 P80202 →
Q61271 1.000 Q61271 →
P36898 1.000 P36898 →
Q64729 1.000 Q64729 →
P80204 1.000 P80204 →
P36895 1.000 P36895 →
Q90ZK6 1.000 Q90ZK6 →
Q28041 1.000 Q28041 →
P70539 1.000 P70539 →
P37172 1.000 P37172 →
Q5CD18 0.999 Q5CD18 →
O46680 0.999 O46680 →
P80201 0.999 P80201 →
P80203 0.997 P80203 →
Q8NER5 0.995 Q8NER5 →
TGFBR1 TGF-beta receptor type-1 0.995 landscape →
BMPR1A Bone morphogenetic protein receptor type-1A 0.995 landscape →
Q24468 0.995 Q24468 →
Q61288 0.994 Q61288 →
Q8K348 0.994 Q8K348 →
ACVR1B Activin receptor type-1B 0.994 landscape →
Q09488 0.992 Q09488 →
ACVR1 Activin receptor type-1 0.990 landscape →
EPHA6 Ephrin type-A receptor 6 0.990 landscape →
EPHA5 Ephrin type-A receptor 5 0.989 landscape →
Q5RAN0 0.989 Q5RAN0 →
Q60629 0.988 Q60629 →
P54757 0.988 P54757 →